Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

01. August 2017 08:00 ET | Quelle: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals® to Host Conference Call to Discuss Second Quarter 2017 Financial and Operating Results

BOTHELL, Wash., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today...
31. Juli 2017 07:30 ET | Quelle: Accelerate Diagnostics, Inc.

Accelerate Diagnostics Welcomes Dr. Romney Humphries as Chief Scientific Officer

TUCSON, Ariz., July 31, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today the addition of Romney Humphries, PhD, D(ABMM), M(ASCP) to its executive management team as Chief...
28. Juli 2017 08:00 ET | Quelle: NewLink Genetics Corporation

NewLink Genetics Reports Second Quarter 2017 Financial Results and Updates Indoximod Program

AMES, Iowa, July 28, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today reported consolidated financial results for the second quarter of 2017 and provided updates on its...
27. Juli 2017 16:05 ET | Quelle: Integer Holdings Corporation

Integer Holdings Corporation Reports Second Quarter 2017 Results

~ Results Reflect Continued Sales Growth; Company Increases Low End of Sales Outlook ~~ Full Year Non-GAAP Adjusted EPS Outlook Updated for Impact of Foreign Currency Losses ~~ Adjusted EPS Outlook...
27. Juli 2017 07:00 ET | Quelle: NewLink Genetics Corporation

NewLink Genetics Announces First Patient Dosed in Phase 1 Study of IDO Pathway Inhibitor NLG802

AMES, Iowa, July 27, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced first patient dosed in the Phase 1 study of NLG802, a novel prodrug of indoximod. NLG802 is...
24. Juli 2017 08:30 ET | Quelle: Sientra Inc.

Sientra(R) to Release Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, August 9, 2017

SANTA BARBARA, Calif., July 24, 2017 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company (“Sientra or the “Company”), announced today that the Company will release its...
24. Juli 2017 08:00 ET | Quelle: Spectral Medical Inc.

FDA Accepts Spectral's PMA for Toraymyxin(TM) for Review

TORONTO, ONTARIO--(Marketwired - July 24, 2017) - Spectral Medical Inc. (TSX:EDT), a Phase III company developing the first treatment for patients with septic shock, today announced that...
18. Juli 2017 17:38 ET | Quelle: Accelerate Diagnostics, Inc.

Accelerate Diagnostics Schedules Call to Review Second Quarter 2017 Results for August 3rd

TUCSON, Ariz., July 18, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Thursday, August 3, 2017 to discuss its second quarter 2017 financial...
18. Juli 2017 07:00 ET | Quelle: RedHill Biopharma Ltd.

RedHill Biopharma to Host Second Quarter 2017 Financial Results Conference Call on July 25, 2017

TEL-AVIV, Israel and RALEIGH, N.C., July 18, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical...
17. Juli 2017 08:30 ET | Quelle: Sonendo

Sonendo® 2017 Red Herring Top 100 North America Winner In Medical Device Category

LAGUNA HILLS, Calif., July 17, 2017 (GLOBE NEWSWIRE) -- Sonendo®, Inc., announced today it has been named one of the winners of the Red Herring Top 100 North America 2017, recognizing the...

Vorherige Seite

Nächste Seite